Slaughter M S, Nielsen K, Bolman R M
Division of Cardiovascular and Thoracic Surgery, University of Minnesota, Minneapolis 55455-0392.
ASAIO J. 1993 Jul-Sep;39(3):M453-6. doi: 10.1097/00002480-199307000-00060.
Extracorporeal membrane oxygenation (ECMO) has proven to be life-saving in cases of reversible lung injury. One potential application of ECMO in the field of lung transplantation is the support of the patient with acute pulmonary failure immediately after transplantation until the transplanted lung has resumed satisfactory gas transfer function. The authors have had experience with ECMO in three patients who have had acute pulmonary failure and inadequate oxygenation after bilateral single lung (BSLT) or heart-lung transplantation (HLT). Patient 1 is a 47-year-old woman with alpha-1 antitrypsin deficiency who underwent a HLT and experienced fulminant pulmonary edema secondary to an intraoperative coagulopathy that required massive transfusion. Patient 2 was a 45-year-old man with a patent ductus arteriosus (PDA) that resulted in Eisenmenger's complex. Patient 2 underwent an HLT and experienced acute pulmonary failure. Patient 3 is a 58-year-old woman with an atrial septal defect (ASD) and pulmonary hypertension who underwent repair of the ASD and BSLT. Patient 3 experienced complete atelectatic collapse of the right lung and pulmonary edema of the left lung. These three patients had PO2 measurements of 23, 39, and 23 mmHg, respectively, despite receiving 100% FiO2 and maximal ventilatory support. All three patients were subsequently placed on ECMO and had improvement of their oxygenation. Patients 1 and 3 were successfully weaned from ECMO and extubated on post-operative day (POD) 21 and 16, respectively. Patient 2 had significant improvement in oxygenation but died on POD 4 of persistent mediastinal hemorrhage.(ABSTRACT TRUNCATED AT 250 WORDS)
体外膜肺氧合(ECMO)已被证明在可逆性肺损伤病例中能挽救生命。ECMO在肺移植领域的一个潜在应用是在移植后立即支持急性肺衰竭患者,直到移植肺恢复令人满意的气体交换功能。作者有3例急性肺衰竭且在双侧单肺移植(BSLT)或心肺移植(HLT)后氧合不足患者应用ECMO的经验。患者1是一名47岁的α-1抗胰蛋白酶缺乏症女性,接受了HLT,因术中凝血病继发暴发性肺水肿,需要大量输血。患者2是一名45岁男性,患有动脉导管未闭(PDA)导致艾森曼格综合征。患者2接受了HLT并发生急性肺衰竭。患者3是一名58岁女性,患有房间隔缺损(ASD)和肺动脉高压,接受了ASD修复和BSLT。患者3出现右肺完全肺不张塌陷和左肺水肿。尽管给予100%的FiO2和最大通气支持,这3例患者的PO2测量值分别为23、39和23 mmHg。所有3例患者随后均接受ECMO治疗,氧合情况得到改善。患者1和3分别在术后第21天和第16天成功脱离ECMO并拔管。患者2的氧合情况有显著改善,但在术后第4天因持续性纵隔出血死亡。(摘要截短于250字)